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Abstract 
 
Background: The aim of this study was to evaluate of the use of herbal products in patients in both pre- and post-
surgery periods and during chemotherapy, and to determine the factors behind it. 
Materials and Methods: This study was conducted as a descriptive study with 281 patients in 4 centers. The data of 
the study were collected by using a survey form prepared by the researcher, depending on literature and interview with 
the participants face-to-face.  
Results: While the average age of the patients involved in the study is 49.1±12.8, 51.6% of them were females, 34.6% 
graduate of elementary school, and 34.5% were housewives. While the prevelance of the use of herbal product prior to 
surgical treatment is 38.9%, it was observed that this rate increased to 54.1% during chemotherapy. It was observed 
that the most frequently used product was garlic prior to surgical treatment (19.2%), that it was urtica dioica (13.8%) 
during chemotherapy. Before the surgical treatment, 94.3% of the patients, and during chemotherapy treatment, 81.7% 
of the patients, stated that the use of herbal product had not been questioned by the physician or nurse.    
Conclusion: Analysis of the results indicates that health professionals need to obtain information regarding the use of 
herbal products by cancer patients during both pre- and post- surgery periods, as well as during chemotherapy. Patients 
should be provided with information and guidance about the advantages and disadvantages of using herbal products.  
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Introduction 
 
 
 Although there are many treatment modalities for cancer, such as surgery, radiotherapy, immunotherapy and 
chemotherapy, it has been noted that the use of complementary and alternative therapies (CAT) has been on the rise 
and that studies in several countries have found the incidence of these therapies to vary between 7% and 64% (with an 
average of 31.4%). While the use of CAT in cancer patients in the USA and Europe is 38.3% and 35.9%, respectively, 
a study that covered 14 European countries, including Turkey, has found an average rate of 36% (Molassiotis et al. 
2005; Langhorne et al. 2007; Uğurluer et al., 2007; Kim and Karver, 2012; Kav et al., 2008, Barnes et al 2008). The 
patients resort to the CAT in order to fight against cancer and prevent recurrence, to minimize side-effects and to 
increase their quality of life (Block et al.,2004;Yarar and Yarış, 2009; Trogrlic et al., 2016). 
In the use of herbal products, which is one of the CAT methods, toxic, allergic and carcinogenic effects can be 
observed in patients before chemotherapy and surgery, due to drug-drug and plant-drug interaction. The incidence of 
morbidity and mortality might be increased in the pre-operative period, due to polypharmacy and drug interactions 
(Bovil, 1997; Breidenbach et al., 2000). For example, Echinacea (Echinacea purpurea-pallida-angustifolia) is the most 
frequently used herb by surgery patients, and its long-term use (generally eight weeks) may cause suppression of 
immune system, and increase the toxicity of barbiturates and the hepatotoxic effects of the steroids, amiodarone, 
methotrexate, ketoconazole and halothane. Likewise, garlic preparations whose most serious side-effect is increased 
bleeding, may change the pharmacokinetic variables of paracetamol if taken together, reduce the blood level of 
warfarin, and cause hypoglycemia when taken together with chlorpropamide (Kumar et al., 2005; Gratus et al., 2009; 
Aral et al., 2011). 
If the herbal products are used after surgery, they may interact with the chemotherapy agents as well, causing 
serious side-effects, dramatically increasing the effects of the chemotherapy agent, or destroying its effectiveness 
completely. For example, St John’s wort which has such side-effects as nausea and hypersensitivity, interacts with 
almost all chemotherapy agents, reduce the active metabolite of irinotecan and cause the reduction of the plasma 
concentration of cyclophosphamide. Senna (Cassia Acutifolia veya C. Angustifolia) is frequently used for the treatment 
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of constipation that arises as a side-effect of chemotherapeutic agents. If used in excess of the required doses, it may 
cause violent diarrhea and damage intestinal epithelia (Richardson et al., 2000; Yarar and Yarış, 2009).  
 
The aim of this study was to evaluate the use of herbal products in cancer patients who had undergone surgery 
and received chemotherapy, and the factors involved.  
 
Materials and Methods 
Study design 
 
This work has been carried out as a descriptive, cross-sectional study for the purpose of examining the use of 
herbal products in cancer patients who had undergone surgery and received chemotherapy, and the factors involved in 
the use of the said products.  
 
Setting and sample 
  
The study cohort consisted of 300 patients, who had been diagnosed with cancer, had undergone surgery in 
one of the four research and education hospitals in the province of Ankara, and who had received at least 1 round of 
chemotherapy in the outpatient chemotherapy clinics of these hospitals. All patients were at least 18 years old, with 
open consciousness and no orientation problems, no issues of communication, and all had agreed to take part in the 
study. The sample size had been determined using the sampling formula as 281 before determining the cohort, and 
patients were then admitted into the study (Çıngı, 1990). 
 
Data Collection Methods and the Process of Data Gathering 
 
The study data were obtained by using a survey form that had been prepared by literature, by conducting face-
to-face interviews with the participants. The survey form consisted of three parts-demographic data such as age, 
gender, marital status, diagnosis, date of diagnosis, current situation of disease, treatment modes, chemotherapy 
situation, and whether patients had used herbal products before. During the interviews, the “ word” cancer was not 
used, taking into account the possibility that some patients might not be aware of their diagnosis. Instead of the term 
“cancer,” the phrase “this disease” was used. The diagnosis, the level of cancer, chemotherapy received and such 
information were taken from the patient’s dossier.  
 
 
Data analysis 
 
The data of the study were collected by using the survey form prepared by the researcher, though depending 
on the literature and interview with the participants face-to-face. The data obtained in this study was analysed by using  
X-square analysis, Fisher’s Exact Test, and Pearson X-square analysis. In the interpretation of the results, value of 
p<0.05 was considered statistically significant. 
 
Variables of the Study 
 
The control variable of the study is the patients’ use of herbal product. The independent variables are age, sex, 
education level, profession, marital status, geographical region of their residence, disease progression, trust in medical 
treatment, belief in the benefits of herbal products, reasons for and purposes of using herbal products, and sources of 
information for the patients.  
 
Ethical consideration 
 
Written consent was taken from the Ethical Committee of Yıldırım Beyazıt University, as well as from the 
hospitals through the Public Hospitals Institution of Turkey, which is established under the Turkish Ministry of Health.  
 
 
Results 
 
The sociodemographic distribution of the patients is shown in Table 1. 
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Table 1: Distribution of the patients according to their sociodemographic status (n=281) 
 
Properties  n % 
Gender 
Female 145 51.6 
Male 136 48.4 
Age 
20-34  41 14.5 
35-49  107 38.1 
50-64  97 34.3 
65-79  32 11.4 
80-94  5 1.7 
Educational Attainment 
Illiterate 34 12 
Literate (no degree) 43 15.3 
Primary&secondary school 97 34.6 
High school 80 28.5 
University graduate 27 9.6 
Marital status 
Single 29 10.3 
Married 252 89.7 
Employment status 
Employed 24 8.5 
Unemployed 159 56.6 
Forced to leave work 98 34.9 
Occupation 
Housewife 97 34.5 
Retired 79 28.2 
Student 4 1.4 
Freelance employment 62 22 
Salaried employment 39 13.9 
Health Insurance 
No 34 12.1 
Yes 247 87.9 
Family Type 
Nuclear 226 80.4 
Extended 42 15 
Divided 13 4.6 
Income Level (monthly) 
Less than 1000 TL 79 28.1 
Between 1000 TL and 3000 TL 191 68 
More than 3000 TL 11 3.9 
Settlement Type of 
Residence 
Village 32 11.4 
County center 184 65.5 
Provincial center 65 23.1 
 
 It was determined that 77.9% of the patients had primary cancer. Likewise, 71.2% of the patients had been 
operated due to an internal organ cancer. 75.5% of the patients had been operated on once, while 77.2% had been 
operated within 12 months. Moreover, it was determined that 81.1% of the patients did not have another chronic 
disease and that 79.7% of them did not use other drugs.  
 The use of herbal products before surgery was 38.9%. It was found that the most widely used herbal products 
were ginger (19.3%) and nettle (8.3%). The main reasons for which the patients used herbal products in this period 
were determined as follows: The patients believed that they are beneficial (40.7%), and they were influenced by their 
acquaintances (31.5%). The use of herbal products during chemotherapy was 54.1%. The most widely used herbal 
product in this period was nettle (13.7%). The main reasons for using herbal remedies in this period were to reduce 
patient complaints (41.1%), and to decrease the side-effects of chemotherapy (32.4%).  
21% of the patients were found to use various herbal products for the complaints listed in Table 2. 5.9% of the 
patients using herbal products were found to use ginger for nausea, and 3.9% used flaxseed for constipation. 1.2% of 
the patients who had experienced side-effects of the herbal products stated that they had stomach ache while using 
nettle (Table 2). 
 
 
Kocasli et al., Afr J Tradit Complement Altern Med., (2017) 14 (2): 325-333 
doi:10.21010/ajtcam.v14i2.34 
328 
 
Table 2: Herbal products used for complications due to chemotherapy and the distribution of side-effects due to their 
use (n=152). 
Distribution of herbal products used for complications due to chemotherapy 
Complications 
Herbal products employed against 
these complications 
N % 
Nausea Ginger 9 5.9 
Constipation Flaxseed 6 3.9 
Mouth sores Echinacea 4 2.6 
Fatigue Green tea 4 2.6 
Coughing Ginger 3 2 
Diarrhea Camomile tea 2 1.3 
Indigestion Licorice root 2 1.3 
Anxiety St John’s wort 1 0.7 
Loss of appetite Licorice root 1 0.7 
Side effects of the herbal products 
Observed side effect Herbal product responsible  N % 
Stomach ache Nettle 2 1.3 
Nausea Licorice root 1 0.7 
Hypotension Goldenseal root 1 0.7 
Indigestion Grapeseed 1 0.7 
Diarrhea Green tea 1 0.7 
It was evident from  the study that 39.8% of the patients were influenced by the media, and 20% by the 
internet (Figure 1).  
 
Figure 1: Distribution of the factors that influence the use of herbal products (n= 156) 
26%
26%20%
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12%
1% 1% Media (newspapers, magazines, TV
programs, radio programs etc)
Friends& family
Internet
Spice stores
Other cancer patients
Own physician
Other
 
83% of the patients revealed that they obtained herbal products from the spice stores. 63.4% of the patients 
stated they spent less than 100 TL monthly, while 22.4% reported spending between 100 and 250 TL (Table 3).   
 
Table 3: Acquisition methods for the herbal products and the expenditures incurred (Monthly) (n=156) 
Mode of acquisiton and the monthly expenditures incurred for the herbal products used  n % 
Mode of acquisition for the herbal 
products 
Spice stores 130 83.3 
Gathering from the nature 46 29.5 
Through social relations (friends and family) 44 28.2 
Internet (online purchases) 41 26.2 
Pharmacies 10 6.4 
Other 10 6.4 
Monthly expenditure for the herbal 
products  
Less than 100 TL 99 63.4 
Between 100 and 250 TL 34 21.8 
Between 250 and 500 TL 11 7.1 
Did not pay any money, obtained through other means 9 5.8 
More than 500 TL 3 1.9 
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While the use of herbal products before surgery was not questioned by the physician or the nurse at a rate of 
94.3%, the same rate was found to be 81.8% during chemotherapy.  49.8% of the patients stated that their doctor did 
not interfere with the use of herbal products, while 27.2% said they did not talk about this issue with their doctors at all 
(Table 2). 
 
Table 2: Questioning of the use of herbal products, either by the physician or the nurse, before surgery or during 
chemotherapy 
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A statistically significant relationship was found between the employment status and the use of herbal 
products in the pre-surgery period. It was seen that patients who were employed were more likely to use herbal 
products (p<0.05). In addition, family type and the settlement type of residence were both seen to be correlated to the 
use of herbal products in the pre-surgery period as well as during chemotherapy. The majority of the patients using 
herbal products belonged to nuclear families and lived in provincial centers (p<0.05). There is a statistically significant 
correlation between the educational attainment level and the use of herbal remedies during chemotherapy (p<0.05). The 
highest rate of herbal product use was observed among college graduates (63%), and the least among illiterate patients 
(32.4%) (Table 4). 
 
Table 4: Socio-demographic characteristics of the patients and their use of herbal remedies before surgery and during 
chemotherapy 
Socio-demographic Characteristics  
Use of herbal remedies before surgery (N=109) Qi Square 
Test No Yes Total 
n % n % N % 
Qi 
Squar
e 
p 
Employment 
status 
Employed 7 28.2 17 70.8 24 100 
9.461 0.009 Unemployed 97 61 62 39 159 100 
Forced to leave work 
while employed 
68 69.4 30 30.6 98 100 
Family type 
Nuclear 128 56.7 98 43.3 226 100 
10.471 0.005 Extended 34 81 8 19 42 100 
Divided 10 76.9 3 23.1 13 100 
Settlement type 
of residence 
 
Village 23 71.9 9 28.1 32 100 
13.455 0.001 County center 121 65.8 63 34.2 184 100 
Provincial center 28 42.6 37 57.4 65 100 
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Characteristics  
Use of herbal remedies during chemotherapy 
(N=152) 
Qi Square 
Test 
No Yes Total 
n % n % N % 
Qi 
Squar
e 
p 
Educational 
attainment 
Illiterate 23 67.6 11 32.4 34 100 
10.516 0.033 
Literate (no degree) 25 58.1 18 41.9 43 100 
Primary-secondary 41 42.2 56 57.8 97 100 
Highschool 30 37.5 50 62.5 80 100 
College 10 37 17 63 27 100 
Family type 
Nuclear 93 41.1 133 58.9 226 100 
11.37 0.003 Extended 27 64.2 15 35.8 42 100 
Divided 9 69.2 4 30.8 13 100 
Settlement type 
of residence 
Village 16 50 16 50 32 100 
7.691 0.021 County center 92 50 92 50 184 100 
Provincial center 21 32.3 44 67.7 65 100 
 
   
 
The use of herbal remedies is correlated to the use of other drugs and the existence of other sicknesses in both the pre-
surgery and chemotherapy periods in a statistically significant way (p<0.05). While the use of herbal products was 
higher in patients who had another disease accompanying cancer and used multiple drugs, it was lower in patients who 
did not have  another chronic disease and who did not use other drugs  (Table 5).  
 
Table 5: The medical status of the patients and their use of herbal remedies before surgery and during chemotherapy. 
Characteristics  
Use of herbal remedies before surgery (N=109) Qi Square 
Test No Yes Total 
n % n % N % 
Qi 
Squa
re 
p 
Other drugs used 
No 146 65.1 78 34.9 224 100 
7.159 0.007 
Yes 26 45.6 31 54.4 57 100 
Any other 
accompanying 
chronic disease 
No 147 65 79 35 226 100 
7.698 0.006 Yes 25 45.5 30 54.5 55 100 
Yes 17 30.9 38 69.1 55 100 
Characteristics  
Use of herbal remedies during chemotherapy (N=152) Qi Square 
Test No Yes Total 
n % n % N % 
Qi 
Squa
re 
p 
Other drugs used 
No 113 50.4 111 49.6 224 100 
7.159 0.007 
Yes 16 28 41 72 57 100 
Any other 
accompanying 
disease 
No 112 49.5 114 50.5 226 100 
6.988 0.008 Yes 17 30.9 38 69.1 55 100 
Yes 113 50.4 111 49.6 224 100 
 
Discussion 
 
 In literature, patients with chronic disease are identified as patients who use multiple drugs, who are generally 
in advanced age, and who prefer alternative treatments in high percentages. This situation could be due to the patient 
taking a more active role in his or her health, as a result of having a chronic disease and suffering due to that disease.  
Hence, the possibility of alternative products interacting with drugs increases (Akyürek, 2005; Adams and Jewell, 
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2007; Sarınca, 2012; Oğur, 2015). In accordance with the literature, it has been found that there is a statistically 
significant correlation between the use of herbal products and the condition of having a chronic disease, for both before 
and after surgery periods. In those patients who suffered from another disease and use multiple drugs, the use of herbal 
product was found to be higher, both before surgery and during chemotherapy.  Unlike medical drugs, herbal products 
contain a lot of active ingredients. For that reason, interactions between herbal products and drugs can be more 
numerous and frequent than those between drugs. (Block et al., 2004; Aşçı, 2007; Aydos, 2011). The finding that the 
use of herbal products is at a higher level in patients using multiple drugs implies that health professionals must be 
more careful for the herbal product-drug interactions that may arise in these patients, it is vital to explain to the patient 
that he/she might experience different complications instead of beneficial effects, and the critical role the nurse should 
play at every step of the treatment (Teng et al., 2010).   
 In the data published in 2008 by NCCAM and the US National Health Statistics Center on the use of CAT in 
the US, the most frequently used CAT agents were natural products other than minerals and vitamins (Barnes et al., 
2007). In a study that was carried out in 14 European countries, including Turkey, on the use of CAT agents by 
Molassiotis et al (2005), herbal treatments were found to be the most widely used method. There are a number of 
studies in Turkey on this topic, too.  In the studies conducted until now, the use of at least one CAT agent was found to 
vary between 36% and 60.1% (Gözüm et al., 2003; Kav et al., 2008; Oğur, 2015). In a literature survey conducted by 
Kav et al in 2008, 14 research articles and 7 studies presented at national conferences were compiled and a combined 
dataset of 5252 patients were constructed. It was found in this literature survey that the prevalence of CAT use varied 
between 22.1% and 84.1%, and nettle was the most widely used herb. In our study, the use of herbal products before 
surgery was 38.9%, while the corresponding rate after surgery and during chemotherapy was 54.1%. The most widely 
used herb was garlic for the period before surgery (19.3%), and nettle during chemotherapy and after surgery (13.7%). 
Some possible reasons behind these choices may be as follows: Garlic and nettle are known with their antioxidant 
properties, they are suitable to the palate of the people in Turkey, and they are easily obtained and cheap (Kucukoner et 
al., 2013). 
 In the literature, among the reasons that lead patients to use CAT methods, the following are listed: Having 
done everything possible against the disease, desperation, increasing the resilience of the body in the struggle against 
cancer, desire to feel better, and just hoping that it may work (Paltiel et al., 2001; Block et al., 2004; Cui et al., 2004; 
Hyodo et al., 2005; Scott et al., 2005; İnanç et al., 2006; Kav et al). Likewise, our study’s findings were consistent with 
the literature. In the period before surgery, top reasons for which patients used herbal products were: belief that herbal 
products would be beneficial (40.7%), influence of family and friends (31.5%), and the desire to try anything that could 
be of help (27.8%). Top reasons for the use of herbal products after surgery were: reducing complaints (41.1%), 
reducing the side-effects of chemotherapy (32.4%), strengthening the immune system (25.2%), and supporting the 
treatment prescribed by the physician (25.2%). The most widely used herbal products in this period were ginger (5.9%) 
for nausea and flaxseed for constipation (3.9%). Besides their effect on healing, chemotherapeutic agents have certain 
side-effects, such as nausea, vomiting, hair loss, diarrhea, and suppression of bone marrow.  When patients receive 
cancer diagnosis, they think they have come to the end of their lives, they would be separated from their loved ones, 
and they would suffer terrible pain. The outcome of this study is in harmony with these feelings of the patients in that 
in the post-surgery phase, they prefer using a variety of herbal products in order to reduce the side-effects of 
chemotherapy, and increase their comfort level and the quality of life. 
 The cytotoxic drugs employed during chemotherapy may interact with other drugs and herbal products being 
used. These interactions affect the healing process of the patients in undesirable ways, cause side-effects and reduce the 
efficacy of the cytotoxic drugs. In a study conducted by the US Department of Health (2001), a number of findings 
were reported regarding the side effects that arise out of drug-herbal product interactions. In a study by Bilge (2010) 
37.9% of the patients reported having seen benefits of the herbal products, while 42.8% said they did not see any 
benefits and 6.70% said they experienced harmful effects. 5 patients reported nausea, 2 patients reported skin burns, 1 
patient reported mouth sores,  1 patient reported skin rashes and 2 patients reported gastric bleeding. Our study’s 
findings are in agreement with the literature, as 4.1% of the patients reported having experienced side effects of the 
herbal product that they used during chemotherapy. 1.2% of the patients using herbal products stated that they 
experienced stomach aches when using nettle. Besides, there was one patient each that linked licorice root to nausea, 
goldenseal root to hypotension, grape seed to indigestion and green tea to diarrhea. 
 In a study by Yarar (2014), physicians were asked what they knew about their patients’ use of herbal products, 
in which dosages these herbal products were used by them, how they were taken, and their side-effects. Responses of 
194 physicians (92.4%) were then evaluated. 4.6% of the respondents stated they knew about the patients using herbal 
products, while 29.4% had partial information and 66% did not have any information. In a study conducted by Barnes 
et al (1998), 69% of the herbal product users would not inform their physicians if a side-effect arose. In another study 
by Bacchini et al (2008) 58% of the individuals purchasing herbs and herbal products kept it secret from their 
physicians. In our study, 81.8% of the patients said that if they used herbal products they would not share this 
information with their doctors. 49.8% of the patients stated that their doctors did not interfere with herbal product use. 
Moreover, neither the nurses nor the physicians questioned the use of herbal products in 94.3% of the patients in the 
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pre-surgery period, while the corresponding rate for the post-surgery period 81.8%. This shows why it is important to 
take the patients’ medical history of drug and herbal product use in a very careful way, to question if new symptoms or 
drug-drug or drug-herbal product interactions arise in patients using herbs or herbal products alongside drugs, and to 
take record of potential side effects. 
 It is seen in the literature that patients using alternative products are generally influenced by TV programs or 
the internet. It is thought that media exposure is increasing the frequency of usage for these products. Some of the 
reasons for the increasing use of the herbal products among the alternative treatments are the lack of a standardized 
supervision, and hence ease of access for these products, increased exposure to the masses thanks to the visual and 
printed media TV channels and the press  (Dedeoğlu, 2014; Oğur, 2015). In a study carried out by Barnes et al (2008) 
in the US, patients requested information on herbal products, either from the books or brochures about them (90.4%) or 
from their doctors (50%). In a study conducted by Kav et al (2008), patients are seen to head towards CAT treatments 
through the guidance of their close acquaintances such as family and friends. Our study parallels the findings in the 
literature. It was found that the media and the patients’ acquaintances were influential at a rate of 39.8%. This shows 
the importance of effective and correct public communications on health issues and the necessity of  reorganizing the 
health programming in the media that informs the public in an unbiased and correct way. 
 
Conclusion and Recommendations 
 
In the light of the data that this study produced, it is recommended that CAT should be included in the curricula of 
the schools of nursing and medicine, courses should be created for the nurses and physicians to increase their 
knowledge about CAT, medical history forms of the patients should be redesigned to identify their use of CAT, and 
more studies should be undertaken to determine the level of information and the opinions of patients, nurses and 
physicians regarding herbal products. 
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